Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) has received an average rating of “Hold” from the nine ratings firms that are presently covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $21.1111.
Several equities research analysts have issued reports on the company. Wells Fargo & Company increased their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Jefferies Financial Group reiterated a “buy” rating and set a $22.00 price objective on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Wall Street Zen downgraded Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Friday, January 23rd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Thursday, January 22nd. Finally, Truist Financial increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a report on Tuesday, January 20th.
Check Out Our Latest Stock Analysis on Sabra Healthcare REIT
Institutional Inflows and Outflows
Sabra Healthcare REIT Price Performance
NASDAQ SBRA opened at $20.17 on Thursday. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. The company has a market cap of $5.09 billion, a PE ratio of 31.52, a price-to-earnings-growth ratio of 1.42 and a beta of 0.67. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $20.54. The firm’s 50-day simple moving average is $19.06 and its two-hundred day simple moving average is $18.79.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). The business had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same period last year, the firm earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts predict that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.
Sabra Healthcare REIT Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Shareholders of record on Friday, February 13th will be paid a $0.30 dividend. The ex-dividend date is Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio is currently 187.50%.
Sabra Healthcare REIT Company Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
Featured Articles
- Five stocks we like better than Sabra Healthcare REIT
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
